Holbrook Edwin Kohrt—In memoriam

Por Kohrt, Holbrook
Publicado no Hum Vaccin Immunother (2016)

Nonmyeloablative conditioning with total lymphoid irradiation and antithymocyte globulin: an update

Por Kohrt, Holbrook, Lowsky, Robert
Publicado em 2009

CD137 stimulation enhances the vaccinal effect of anti-tumor antibodies

Por Houot, Roch, Kohrt, Holbrook
Publicado no Oncoimmunology (2014)

Boosting antibody-dependant cellular cytotoxicity against tumor cells with a CD137 stimulatory antibody

Por Houot, Roch, Kohrt, Holbrook, Levy, Ron
Publicado em 2012

Intratumoral Anti-CTLA-4 Therapy: Enhancing Efficacy While Avoiding Toxicity

Por Marabelle, Aurélien, Kohrt, Holbrook, Levy, Ronald
Publicado em 2013

Monitoring the immune competence of cancer patients to predict outcome

Por Chang, Serena, Kohrt, Holbrook, Maecker, Holden T.
Publicado em 2014

New insights into the mechanism of action of immune checkpoint antibodies

Por Marabelle, Aurélien, Kohrt, Holbrook, Levy, Ronald
Publicado no Oncoimmunology (2014)

Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy

Por Chester, Cariad, Fritsch, Katherine, Kohrt, Holbrook E.
Publicado no Front Immunol (2015)

4-1BB agonism: adding the accelerator to cancer immunotherapy

Por Chester, Cariad, Ambulkar, Siddhant, Kohrt, Holbrook E.
Publicado no Cancer Immunol Immunother (2016)

Renal Failure and Rhabdomyolysis Associated With Sitagliptin and Simvastatin Use

Por Kao, David P, Kohrt, Holbrook E, Kugler, John
Publicado em 2008

Selective Resistance of CD44(hi) T Cells to p53 Dependent Cell Death Results in Persistence of Immunologic Memory after Total Body Irradiation(1,2,3)

Por Yao, Zhenyu, Jones, Jennifer, Kohrt, Holbrook, Strober, Samuel
Publicado em 2011

Intratumoral Immunization: A New Paradigm for Cancer Therapy

Por Marabelle, Aurélien, Kohrt, Holbrook, Caux, Christophe, Levy, Ronald
Publicado em 2014

Immunotherapeutic approaches to ovarian cancer treatment

Por Chester, Cariad, Dorigo, Oliver, Berek, Jonathan S, Kohrt, Holbrook
Publicado no J Immunother Cancer (2015)

A quantitative analysis of therapeutic cancer vaccines in phase 2 or phase 3 trial

Por Tan, Amabel CL, Goubier, Anne, Kohrt, Holbrook E.
Publicado no J Immunother Cancer (2015)

NKT cells, Treg, and their interactions in bone marrow transplantation

Por Kohrt, Holbrook E., Pillai, Asha B., Lowsky, Robert, Strober, Samuel
Publicado em 2010

Enhancement of antibody-dependent cell mediated cytotoxicity: a new era in cancer treatment

Por Rajasekaran, Narendiran, Chester, Cariad, Yonezawa, Atsushi, Zhao, Xing, Kohrt, Holbrook E
Publicado no Immunotargets Ther (2015)

Ibrutinib enhances the antitumor immune response induced by intratumoral injection of a TLR9 ligand in mouse lymphoma

Por Sagiv-Barfi, Idit, Kohrt, Holbrook E., Burckhardt, Laura, Czerwinski, Debra K., Levy, Ronald
Publicado no Blood (2015)

Predicting CD137 upregulation on NK cells in patients receiving monoclonal antibody therapy

Por Makkouk, Amani, Sundaram, Vandana, Desai, Manisha, Chester, Cariad, Maecker, Holden, Kohrt, Holbrook E
Publicado no J Immunother Cancer (2015)

Profile of Immune Cells in Axillary Lymph Nodes Predicts Disease-Free Survival in Breast Cancer

Por Kohrt, Holbrook E, Nouri, Navid, Nowels, Kent, Johnson, Denise, Holmes, Susan, Lee, Peter P
Publicado em 2005

In-situ tumor vaccination: Bringing the fight to the tumor

Por Pierce, Robert H, Campbell, Jean S, Pai, Sara I, Brody, Joshua D, Kohrt, Holbrook EK
Publicado no Hum Vaccin Immunother (2015)